Publication & Patent

Shuangshuang Wan, Yu Lei, Yue Jin, Runze Wang, Meng Zhang, Qikai Shi, Hui Hu, Yulei Tai, Yun Luo, Zheng Xu, Rong Kuang, Xiaojun Song, Yu Chen, Dazhi Jin
Corresponding author
(2025). Biliverdin targeting TcdB-DRBD inhibits Clostridioides difficile virulence and restores gut microbiota in Mongolian gerbils (Meriones unguiculatus). Communication Biology, 2025, 68, 19, 20389–20409.
PDF Code Source Document
Runze Wang, Qiuyu Zhang, Yi Lin, Yangpei Huang, Yuanfei Yang, Chaoqiang Ni, Chaoqiao Wang, Shuangshuang Wan
Corresponding author
(2025). Virtual Screening and Multistage Computational Profiling of Small-Molecule Inhibitors Targeting Clostridioides difficile Toxin B. Journal of Medicinal Chemistry, 2025, 68, 19, 20389–20409.
PDF Code Source Document
Runze Wang, Shuangshuang Wan, Qiuyu Zhang, Chaoqiang Ni, Chaoqiao Wang (2025). Non-antibiotic small molecule inhibitors of Clostridioides difficile toxin B and screening methods thereof. Chinese Patent Application CN202510777443.X. Hangzhou Medical College.
Shuangshuang Wan, Dazhi Jin, Yu Lei, Runze Wang, Qiuyu Zhang, Yi Lin (2025). Application of pranlukast in preparing anti-Clostridioides difficile infection drugs. Chinese Patent Application CN202510715258.8. Hangzhou Medical College.
Yuanfei Yang, Runze Wang, Zhixuan Hong, Jinbang Shao, Xingyuan Chai, Xiaobo He (2025). Method for identifying silkworm sulfakinin receptor. Chinese Patent Application CN202510380413.5. Hangzhou Medical College.
Dazhi Jin, Shuangshuang Wan, Yu Lei, Runze Wang, Qikai Shi, Xiaojun Song, Hui Hu (2025). Application of biliverdin molecule in preparing drugs for treating Clostridioides difficile infection. Chinese Patent Application CN202510242135.7. Hangzhou Medical College.